nondiabetic patients

Related by string. * nondiabetics : nondiabetic subjects . nondiabetic / PATIENTS . PATIENT . Patients . pa tients . pa tient . Patient : Breast Cancer Patients . terminally ill patients . Patient Safety . chronically ill patients . Improving Patient Outcomes . Patient Centered Medical . Patient Centered Outcomes . patients . Patient Monitoring . enacted Patient Protection . mechanically ventilated patients * *

Related by context. Frequent words. (Click for all words.) 72 % CI #.#-#.# [003] 71 nonobese 70 nondiabetic 70 % CI #.#-#.# [007] 70 HbA 1c 69 confidence interval #.#-#.# 69 HbA1c levels 68 NHANES III 68 liver transplant recipients 68 serum uric acid 68 irbesartan 68 Taxus Stent 67 glycated hemoglobin 67 ischemic cardiomyopathy 67 carotid intima media 67 P = .# 67 #mg/day [001] 67 serum calcium 67 undergoing coronary artery 67 serum concentrations 67 % CI #.#-#.# [006] 67 univariate analysis 66 fasting glucose levels 66 myocardial infarctions 66 left ventricular systolic 66 stable angina 66 chlorambucil 66 myocardial infarction stroke 66 myocardial infarction MI 66 glomerular filtration rate 66 cerebral infarction 66 LVEF 66 coronary revascularization 65 enalapril 65 multivariate analyzes 65 cardiac dysfunction 65 fibrinolysis 65 systolic BP 65 Pioglitazone 65 biochemical recurrence 65 thromboembolism 65 Arch Intern Med 65 severe renal impairment 65 ng dL 65 TAXUS Stent 65 creatinine levels 65 CI -#.# 65 infarct size 65 NYHA class 65 comorbid conditions 65 tolvaptan 65 fasting insulin 65 glycosylated hemoglobin 65 glargine 65 cerebrovascular events 65 lipid lowering drugs 65 endarterectomy 65 TAXUS p value 65 estimated glomerular filtration 65 left ventricular dysfunction 65 CI #.#-#.# [002] 64 NYHA Class III 64 statistically significant p = 64 stenoses 64 creatinine clearance 64 hyperglycaemia 64 antihypertensive medications 64 glycemia 64 pg mL 64 hypoglycemic events 64 HbA1C 64 pg ml 64 nonsignificant 64 μg kg 64 T2DM 64 elevated triglycerides 64 vertebral fracture 64 renal dysfunction 64 apolipoprotein B 63 lung metastases 63 fraction LVEF 63 cardiovascular mortality 63 MetS 63 confidence interval CI 63 systemic embolism 63 HSCT 63 ziprasidone 63 daunorubicin 63 microvascular complications 63 laboratory abnormalities 63 virologic failure 63 Ischemic 63 cardiovascular morbidity 63 glimepiride 63 active comparator 63 mycophenolate mofetil 63 unfractionated heparin 63 acute myocardial infarction AMI 63 candesartan 63 serum phosphorus 63 annualized relapse

Back to home page